Unfortunately, this company sits in the takeover group.
Given likely Spodumene pricing, the current size and grade of the resource, it is not large enough to justify developing. Given the current share price and sentiment, I doubt that they can obtain sufficient funding (CR) to growth the resource. They still have yet to pay for current resource, with I think an amount of $1 m still to be paid.
Ann: Exceptional Assay Results of up to 5.12% Li2O at Mavis Lake, page-3
Add CRR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.24M | |||
| Open | High | Low | Value | Volume |
| 0.9¢ | 0.9¢ | 0.8¢ | $13.88K | 1.620M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 18 | 5822210 | 0.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.9¢ | 384621 | 3 |
View Market Depth
| Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
| CRR (ASX) Chart |